Key result
Higher pre-transplant TTV load is linked to ~30% less acute rejection but more infections and graft failure.
Why the study?
Torque teno virus load is a potential surrogate marker of net immunosuppression, but the clinical significance of pre-transplant levels for early outcomes after lung transplantation remains unclear.
Does pre-transplant Torque teno virus (TTV) load predict early post-transplant infection, acute rejection, and 1-year graft failure in lung transplant recipients?
Does pre-transplant Torque teno virus (TTV) load predict early post-transplant infection, acute rejection, and 1-year graft failure in lung transplant recipients?
Higher pre-transplant plasma TTV load is a strong predictor of early post-transplant infection and 1-year graft failure, but is associated with fewer acute rejection events, highlighting its potential as a biomarker for immune risk stratification.
Answers are grounded in this paper and cite their sources.
Supports pre-transplant TTV for immune risk stratification in lung recipients; hypothesis-generating and requires prospective validation before adoption.
Abstract Background Torque teno virus (TTV) load has emerged as a potential surrogate marker of net immunosuppression in solid organ transplantation. However, the clinical significance of pre-transplant TTV levels for early outcomes after lung transplantation remains unclear. Methods In this multicenter cohort of 334 adult first-time lung transplant recipients (2015–2022), plasma samples were collected immediately prior to transplantation. The primary endpoint was infection within 3 months. One hundred healthy individuals served as controls for TTV comparisons. Secondary outcomes were acute rejection and 1-year graft failure. Associations were evaluated using multivariable logistic regression for early infection and time-to-event analyses for rejection and graft failure. Results Pre-transplant TTV levels were higher in recipients than in controls (6.7 vs 5.9 log₁₀ copies/mL; p<0.001). Early infections occurred in 103 patients (30.8%). Patients with infection had higher pre-transplant TTV levels than those without infection (7.8 vs 6.3 log₁₀ copies/mL; p<0.001). Each 1-log₁₀ increase in TTV was associated with higher infection risk (adjusted odds ratio 15.05; 95% CI 7.25–31.20; p<0.001). Receiver operating characteristic analysis showed good discrimination for identifying early infection (AUC 0.89; 95% CI 0.85–0.92). Higher TTV levels were associated with lower acute rejection risk (adjusted hazard ratio 0.70; 95% CI 0.56–0.87; p=0.001) and higher 1-year graft failure (adjusted hazard ratio 1.40; 95% CI 1.13–1.74; p=0.002). Conclusions Pre-transplant plasma TTV load was associated with early infection, fewer rejection events, and increased 1-year graft failure after lung transplantation, supporting its potential role as a biomarker for immune risk stratification.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) studied this question. Each 1-log10 increase in pre-transplant TTV load in lung recipients increased early infection risk and 1-year graft failure, but reduced acute rejection.
Synapse has enriched 10 related papers. Consider them for comparative context: